BushyMed CBD
BushyMed CBD
Overview
BushyMed CBD is a high-CBD, low-THC cannabis strain developed by Fatbush Seeds, a Spanish cannabis seed bank known for producing CBD-dominant varieties. This strain contains approximately 20% CBD and 0.6% THC, resulting in non-psychoactive effects with a calming and focused impact that keeps users comfortable while maintaining clarity for daily tasks. Fatbush Seeds is based in Spain and specializes in feminized and autoflowering seeds, with a particular focus on CBD products. BushyMed CBD represents the company's commitment to producing therapeutic cannabis varieties with minimal psychoactive properties. The strain is designed for users seeking the medicinal benefits of cannabis without the intoxicating effects typically associated with high-THC varieties. Limited detailed information is available about this strain's specific lineage or breeding history, as it appears to be a relatively specialized offering from a smaller seed company that focuses on quality over extensive marketing.
Effects
Reported Medical Uses
- Users report stress relief
- May help with anxiety management
- Often used for pain management without impairment
- Suitable for daytime therapeutic use
- May assist with focus and concentration
This is not medical advice. Consult a healthcare professional.
Possible Negative Effects
Growing Information
BushyMed CBD is available as feminized seeds from Fatbush Seeds. Growing information is limited, but as a CBD-dominant strain, it likely has a flowering time of 8-10 weeks for photoperiod varieties. The strain appears suitable for both indoor and outdoor cultivation, though specific yield expectations, plant height, and detailed growing requirements are not well-documented. As with most CBD strains, consistent environmental conditions and proper curing are important for maintaining cannabinoid profiles.